Merck naming troubles continue

Share this article:

Same-name problems continue to plague US-based and Germany-based Mercks. Bloomberg reports that while confusion has been an ongoing concern since the companies split in the early 20th century, a recent protest by the StopAIDS group is further proof that a different home base is not enough for activists to go on.

The latest problem is that activists protested the German Merck, known as Merck KGaA, in front of which they pitched a complaint against its move to block low-cost copies of patented drugs from flowing into South Africa, but the company that is actually involved is the Merck which has headquarters in New Jersey.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.